145 related articles for article (PubMed ID: 9212779)
1. Structural features associated with reactive metabolite formation in clozapine analogues.
Uetrecht J; Zahid N; Tehim A; Fu JM; Rakhit S
Chem Biol Interact; 1997 May; 104(2-3):117-29. PubMed ID: 9212779
[TBL] [Abstract][Full Text] [Related]
2. Predicting drug-induced agranulocytosis: characterizing neutrophil-generated metabolites of a model compound, DMP 406, and assessing the relevance of an in vitro apoptosis assay for identifying drugs that may cause agranulocytosis.
Iverson S; Zahid N; Uetrecht JP
Chem Biol Interact; 2002 Nov; 142(1-2):175-99. PubMed ID: 12399162
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the oxidation of clozapine and olanzapine to reactive metabolites and the toxicity of these metabolites to human leukocytes.
Gardner I; Zahid N; MacCrimmon D; Uetrecht JP
Mol Pharmacol; 1998 Jun; 53(6):991-8. PubMed ID: 9614200
[TBL] [Abstract][Full Text] [Related]
4. Clozapine is oxidized by activated human neutrophils to a reactive nitrenium ion that irreversibly binds to the cells.
Liu ZC; Uetrecht JP
J Pharmacol Exp Ther; 1995 Dec; 275(3):1476-83. PubMed ID: 8531118
[TBL] [Abstract][Full Text] [Related]
5. Bioactivation and covalent binding of hydroxyfluperlapine in human neutrophils: implications for fluperlapine-induced agranulocytosis.
Lai WG; Gardner I; Zahid N; Uetrecht JP
Drug Metab Dispos; 2000 Mar; 28(3):255-63. PubMed ID: 10681368
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the covalent binding of clozapine and olanzapine to human neutrophils in vitro and in vivo.
Gardner I; Leeder JS; Chin T; Zahid N; Uetrecht JP
Mol Pharmacol; 1998 Jun; 53(6):999-1008. PubMed ID: 9614201
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of ticlopidine by activated neutrophils: implications for ticlopidine-induced agranulocytosis.
Liu ZC; Uetrecht JP
Drug Metab Dispos; 2000 Jul; 28(7):726-30. PubMed ID: 10859143
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of clozapine by human neutrophils: evidence for a specific oxidation of clozapine by the myeloperoxidase system with inhibition of enzymatic chlorination cycle.
Frimat B; Gressier B; Odou P; Brunet C; Dine T; Luycky M; Cazin M; Cazin JC
Fundam Clin Pharmacol; 1997; 11(3):267-74. PubMed ID: 9243259
[TBL] [Abstract][Full Text] [Related]
9. Potential role of a quetiapine metabolite in quetiapine-induced neutropenia and agranulocytosis.
Li X; Cameron MD
Chem Res Toxicol; 2012 May; 25(5):1004-11. PubMed ID: 22506851
[TBL] [Abstract][Full Text] [Related]
10. Effect of clozapine and olanzapine on neutrophil kinetics: implications for drug-induced agranulocytosis.
Ng W; Kennar R; Uetrecht J
Chem Res Toxicol; 2014 Jul; 27(7):1104-8. PubMed ID: 24968069
[TBL] [Abstract][Full Text] [Related]
11. Hypochlorous acid, a major oxidant produced by activated neutrophils, has low effect on two pyridobenzazepine derivatives, JL 3 and JL 13.
Liégeois JF; Zahid N; Bruhwyler J; Uetrecht J
Arch Pharm (Weinheim); 2000 Mar; 333(2-3):63-7. PubMed ID: 10783520
[TBL] [Abstract][Full Text] [Related]
12. Comparative oxidation of loxapine and clozapine by human neutrophils.
Jegouzo A; Gressier B; Frimat B; Brunet C; Dine T; Luyckx M; Kouach M; Cazin M; Cazin JC
Fundam Clin Pharmacol; 1999; 13(1):113-9. PubMed ID: 10027097
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of clozapine by neutrophils. Possible implications for clozapine-induced agranulocytosis.
Uetrecht JP
Drug Saf; 1992; 7 Suppl 1():51-6. PubMed ID: 1503678
[TBL] [Abstract][Full Text] [Related]
14. The metabolic formation of reactive intermediates from clozapine, a drug associated with agranulocytosis in man.
Maggs JL; Williams D; Pirmohamed M; Park BK
J Pharmacol Exp Ther; 1995 Dec; 275(3):1463-75. PubMed ID: 8531117
[TBL] [Abstract][Full Text] [Related]
15. Y-931, a novel atypical antipsychotic drug, is less sensitive to oxidative phenomena.
Kohara T; Koyama T; Fujimura M; Tanaka H; Maeda J; Fujimoto T; Yamamoto I; Arita M
Chem Pharm Bull (Tokyo); 2002 Jun; 50(6):818-21. PubMed ID: 12045338
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of vesnarinone by activated neutrophils: implications for vesnarinone-induced agranulocytosis.
Uetrecht JP; Zahid N; Whitfield D
J Pharmacol Exp Ther; 1994 Sep; 270(3):865-72. PubMed ID: 7932198
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil cytotoxicity of the chemically reactive metabolite(s) of clozapine: possible role in agranulocytosis.
Williams DP; Pirmohamed M; Naisbitt DJ; Maggs JL; Park BK
J Pharmacol Exp Ther; 1997 Dec; 283(3):1375-82. PubMed ID: 9400013
[TBL] [Abstract][Full Text] [Related]
18. Oxidation of diclofenac to reactive intermediates by neutrophils, myeloperoxidase, and hypochlorous acid.
Miyamoto G; Zahid N; Uetrecht JP
Chem Res Toxicol; 1997 Apr; 10(4):414-9. PubMed ID: 9114978
[TBL] [Abstract][Full Text] [Related]
19. Possible role of free radical formation in clozapine (clozaril)-induced agranulocytosis.
Fischer V; Haar JA; Greiner L; Lloyd RV; Mason RP
Mol Pharmacol; 1991 Nov; 40(5):846-53. PubMed ID: 1658615
[TBL] [Abstract][Full Text] [Related]
20. Oxidation of a metabolite of indomethacin (Desmethyldeschlorobenzoylindomethacin) to reactive intermediates by activated neutrophils, hypochlorous acid, and the myeloperoxidase system.
Ju C; Uetrecht JP
Drug Metab Dispos; 1998 Jul; 26(7):676-80. PubMed ID: 9660850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
